Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Non-Myeloablative Conditioning with Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Confirm a Low Incidence of Graft Versus Host Disease (GVHD) with Retained Anti-Tumor Activity

Holbrook Kohrt, MD, Brit Turnbull, PhD, G. Laport, MD, D. Miklos, MD, PhD, J. Shizuru, MD, PhD, L. Johnston, MD, S. Arai, MD, W. K. Weng, MD, PhD, J. Benjamin, MD, PhD, K. Blume, MD, R. Negrin, MD, P. Lavori, PhD, S. Strober, MD, R. Lowsky, MD

Blood (2008) 112 (11): 3310.

https://doi.org/10.1182/blood.V112.11.3310.3310

Published: 2008

Journal Articles

Haploidentical Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Conditioning Protects Against Acute Graft Versus Host Disease (GVHD).

R. Lowsky, K. Heydari, B. Sahaf, J. Shizuru, G. Laport, L. Johnston, K. Stockerl-Goldstein, S. Arai, D. Miklos, K. Blume, L. Herzenberg, R. Negrin, S. Strober

Blood (2005) 106 (11): 2904.

https://doi.org/10.1182/blood.V106.11.2904.2904

Published: 2005

Journal Articles

Donor NK Cell Engraftment and Overall and Progression-Free Survivals after Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning.

Frederic Baron, T. Gooley, M.T. Little, E. Petersdorf, M. Malkki, D. Maloney, M. Maris, P. Stroup, S. Shin, J. Baker, T. Chauncey, K. Blume, B. Sandmaier, R. Storb

Blood (2005) 106 (11): 398.

https://doi.org/10.1182/blood.V106.11.398.398

Published: 2005

Journal Articles

HLA-Matched Unrelated Donor HCT after Nonmyeloablative Conditioning for Patients with Chronic Myeloid Leukemia.

Frederic Baron, M. Maris, B. Sandmaier, B. Storer, M. Stuart, P. McSweeney, J. Radich, M. Pulsipher, E. Agura, E. Petersdorf, S. Heimfeld, T. Chauncey, M.T. Little, D. Maloney, K. Blume, R. Storb

Blood (2004) 104 (11): 2755.

https://doi.org/10.1182/blood.V104.11.2755.2755

Published: 2004

Journal Articles

Unrelated Donor Peripheral Blood Stem Cell (PBSC) Transplantation Using Nonmyeloablative Conditioning and Mycophenolate Mofetil (MMF) TID Results in High Engraftment Rates.

Michael B. Maris, MD, B. M. Sandmaier, MD, B. Storer, PhD, J. Shizuru, MD, PhD, D. Maloney, MD, PhD, E. Agura, MD, PhD, D. Niederwieser, MD, M. Pulsipher, MD, R. T. Maziarz, MD, P. McSweeney, MD, J. Wade, MD, A. Langston, MD, T. Chauncey, MD, B. Bruno, MD, A. Woolfrey, MD, M.T. Little, PhD, K. Blume, MD, R. Storb, MD

Blood (2004) 104 (11): 1818.

https://doi.org/10.1182/blood.V104.11.1818.1818

Published: 2004

Journal Articles

Culture of phenotypically defined hematopoietic stem cells and other progenitors at limiting dilution on Dexter monolayers [see comments]

K Weilbaecher, I Weissman, K Blume, S Heimfeld

Blood (1991) 78 (4): 945–952.

https://doi.org/10.1182/blood.V78.4.945.945

Published: 1991

Journal Articles

Hemoglobin Great Lakes (beta 68 [E12] leucine replaced by histidine): a new high-affinity hemoglobin

S Rahbar, K Winkler, J Louis, C Rea, K Blume, E Beutler

Blood (1981) 58 (4): 813–817.

https://doi.org/10.1182/blood.V58.4.813.813

Published: 1981

NARROW

Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Non-Myeloablative Conditioning with Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Confirm a Low Incidence of Graft Versus Host Disease (GVHD) with Retained Anti-Tumor Activity

Haploidentical Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Conditioning Protects Against Acute Graft Versus Host Disease (GVHD).

Donor NK Cell Engraftment and Overall and Progression-Free Survivals after Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning.

HLA-Matched Unrelated Donor HCT after Nonmyeloablative Conditioning for Patients with Chronic Myeloid Leukemia.

Unrelated Donor Peripheral Blood Stem Cell (PBSC) Transplantation Using Nonmyeloablative Conditioning and Mycophenolate Mofetil (MMF) TID Results in High Engraftment Rates.

Culture of phenotypically defined hematopoietic stem cells and other progenitors at limiting dilution on Dexter monolayers [see comments]

Hemoglobin Great Lakes (beta 68 [E12] leucine replaced by histidine): a new high-affinity hemoglobin

Email alerts

ASH Publications

American Society of Hematology

Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Non-Myeloablative Conditioning with Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Confirm a Low Incidence of Graft Versus Host Disease (GVHD) with Retained Anti-Tumor Activity

Haploidentical Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Conditioning Protects Against Acute Graft Versus Host Disease (GVHD).

Donor NK Cell Engraftment and Overall and Progression-Free Survivals after Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning.

HLA-Matched Unrelated Donor HCT after Nonmyeloablative Conditioning for Patients with Chronic Myeloid Leukemia.

Unrelated Donor Peripheral Blood Stem Cell (PBSC) Transplantation Using Nonmyeloablative Conditioning and Mycophenolate Mofetil (MMF) TID Results in High Engraftment Rates.

Culture of phenotypically defined hematopoietic stem cells and other progenitors at limiting dilution on Dexter monolayers [see comments]

Hemoglobin Great Lakes (beta 68 [E12] leucine replaced by histidine): a new high-affinity hemoglobin

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only